 |
Monoclonal antibody-B43.13 |
|---|---|
| Trade Name | Ovarex Mab-B43.13 |
| Orphan Indication | Ovarian epithelial cancer |
| USA Market Approval | USA |
| USA Designation Date | 1996-11-25 00:00:00 |
| Sponsor | Quest PharmaTech, Inc.;9407 20 Avenue, Edmonton, Alberta T6N 1E5; |
Related Access Program